NASDAQ : AEMD
Aethlon Medical, Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 5.44 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 3.87M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 3.87M |
| Enterprise Value | -697,391 |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 11, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 711,136 |
| Shares Outstanding | 711,136 |
| Shares Change (YoY) | +497.17% |
| Shares Change (QoQ) | +52.56% |
| Owned by Insiders (%) | 1.14% |
| Owned by Institutions (%) | 15.76% |
| Float | 703,011 |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.50 |
| P/TBV Ratio | 0.74 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 5.42 |
| Quick Ratio | 4.76 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -492.66 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -160.91% |
| Return on Assets (ROA) | -76.69% |
| Return on Invested Capital (ROIC) | -91.46% |
| Return on Capital Employed (ROCE) | -136.18% |
| Weighted Average Cost of Capital (WACC) | 10.24% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$770,836 |
| Employee Count | 9 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.23 |
| 52-Week Price Change | -81.08% |
| 50-Day Moving Average | 4.47 |
| 200-Day Moving Average | 7.78 |
| Relative Strength Index (RSI) | 53.56 |
| Average Volume (20 Days) | 58,635 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 32,925 |
| Short Previous Month | 75,446 |
| Short % of Shares Out | 4.63% |
| Short % of Float | 4.68% |
| Short Ratio (days to cover) | 0.01 |
Incomestatement
| Measure | Value |
|---|
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -7.08M |
| Pretax Income | -6.94M |
| Net Income | -6.94M |
| EBITDA | -6.77M |
| EBIT | -7.08M |
| Earnings Per Share (EPS) | -$31.45 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 4.93M |
| Total Debt | 367,608 |
| Net Cash | 4.57M |
| Net Cash Per Share | $6.42 |
| Equity (Book Value) | 5.20M |
| Book Value Per Share | 10.89 |
| Working Capital | 4.57M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -7.18M |
| Capital Expenditures | -12,854 |
| Depreciation & Amortization | 313,876 |
| Net Borrowing | n/a |
| Free Cash Flow | -7.19M |
| FCF Per Share | -$10.11 |
Margins
| Measure | Value |
|---|
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -497.17% |
| Shareholder Yield | -497.17% |
| Earnings Yield | -578.14% |
| FCF Yield | -185.93% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $13.25 |
| Price Target Difference | 143.57% |
| Analyst Consensus | Hold |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Aug 4, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:5 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |